These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Thymectomy in the management of myasthenia]. Balzereit F; Bay V; Otto H; Rittmeyer P; Sobirey C Z Neurol; 1972; 201(2):136-59. PubMed ID: 4112645 [No Abstract] [Full Text] [Related]
30. [Therapy of myasthenia gravis]. Jerusalem F Dtsch Med Wochenschr; 1977 Aug; 102(32):1160-3. PubMed ID: 196820 [No Abstract] [Full Text] [Related]
31. Recurrence of nonneoplastic thymus after thymectomy for myasthenia gravis. Report of two cases. Joseph BS; Johns TR Neurology; 1973 Feb; 23(2):109-16. PubMed ID: 4347062 [No Abstract] [Full Text] [Related]
32. Medical and surgical treatment for ocular myasthenia. Benatar M; Kaminski H Cochrane Database Syst Rev; 2006 Apr; (2):CD005081. PubMed ID: 16625623 [TBL] [Abstract][Full Text] [Related]
33. Correlation of the clinical response to ACTH treatment with the endocrine status in myasthenia gravis. Cape CA; Arbona NJ South Med J; 1973 Sep; 66(9):1011-3. PubMed ID: 4354772 [No Abstract] [Full Text] [Related]
34. [Current results of the treatment of pseudoparalytic myasthenia gravis with immunosuppressive agents]. Ricken D Monatsschr Kinderheilkd (1902); 1972 Jun; 120(6):237-41. PubMed ID: 4341360 [No Abstract] [Full Text] [Related]
35. [The Grob test in myasthenia: discussion of an atypical case]. Gambi D; Tonali P Riv Neurol; 1971; 41(3):161-9. PubMed ID: 4331238 [No Abstract] [Full Text] [Related]
36. Crisis, precrisis and drug resistance in myasthenia gravis. Glaser GH Ann N Y Acad Sci; 1966 Jan; 135(1):335-49. PubMed ID: 5221348 [No Abstract] [Full Text] [Related]
37. [Treatment of myasthenia gravis]. Igata A Naika; 1970 Apr; 25(4):676-82. PubMed ID: 5423420 [No Abstract] [Full Text] [Related]
38. [Therapies of myasthenia gravis (author's transl)]. de Crousaz G Schweiz Rundsch Med Prax; 1978 Jan; 67(4):113-7. PubMed ID: 202937 [No Abstract] [Full Text] [Related]
39. [On the relationship between negative effects and positive effects of ACTH therapy in myasthenic patients]. Pinelli P; Gandiglio G Riv Neurol; 1968; 38(2):77-84. PubMed ID: 4298338 [No Abstract] [Full Text] [Related]
40. [Treatment with ACTH in the myasthenic syndrome with an immunological substratum]. Radu H; Roşu AM; Lenkei R; Ionescu V; Darko Z Neurol Psihiatr Neurochir; 1973; 18(4):377-84. PubMed ID: 4356514 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]